BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3067385)

  • 1. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of propranolol and atenolol on peripheral tissue blood flow and effective plasma flow through the kidneys].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1981 Jun; 36(22):797-9. PubMed ID: 7279762
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of adrenergic blockaders in hypertension].
    Zonis BIa; Pashkova TL
    Sov Med; 1986; (2):89-91. PubMed ID: 3518078
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of ethaperazine in the treatment of neurocirculatory asthenia or hypertensive type].
    Tiossa GT
    Zh Eksp Klin Med; 1977; 17(3):105-7. PubMed ID: 906711
    [No Abstract]   [Full Text] [Related]  

  • 5. [Essential circulatory hyperkinesis and tobanum].
    Nagy I
    Orv Hetil; 1982 Feb; 123(9):569. PubMed ID: 6123100
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory dystonia of the cardiac type].
    Orlov LL; Makoeva LD; Glezer MG; Memetov KA; Belinskaia TF; Arzhanenko OM
    Kardiologiia; 1991 Feb; 31(2):36-9. PubMed ID: 2041288
    [No Abstract]   [Full Text] [Related]  

  • 8. [New drugs registered in Austria. Selectol].
    Rameis H
    Wien Klin Wochenschr; 1984 Apr; 96(8):299-302. PubMed ID: 6146230
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol in the treatment of neurocirculatory asthenia--an open pilot study.
    Rimón R; Kampman R; Viukari M
    Isr Ann Psychiatr Relat Discip; 1979 Jun; 17(2):144-8. PubMed ID: 291588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute effects of beta receptor blockaders in hyperthyroidism].
    Váradi A; Földes J; Gyertyánffy G; Borvendég J; Brüll J
    Orv Hetil; 1981 May; 122(18):1069-72. PubMed ID: 6115351
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
    Szám I; Büky P; Gulyás A; Sinkovics M
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late outcome of neurocirculatory asthenia].
    Doshchenko VN; Okladnikova ND
    Sov Med; 1989; (9):120. PubMed ID: 2603031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of vegetative cardio-circulatory disorders using beta receptor blockaders. Double blind study on Pindolol-Visken].
    Engel HJ
    Med Welt; 1972 Jul; 23(27):980-4. PubMed ID: 4559279
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting beta-blockers in the twenty-fourth hour. A comparison in hypertension.
    Hackett GI; Harrison P; Kershaw S
    Practitioner; 1981 May; 225(1355):752-5. PubMed ID: 7027230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Penbutolol and propranolol in the treatment of hypertension. A double-blind comparative study in general practice].
    Astvad K; Krogh A; Sidenius J
    Ugeskr Laeger; 1984 Oct; 146(41):3104-6. PubMed ID: 6393504
    [No Abstract]   [Full Text] [Related]  

  • 17. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
    Prusiński A; Kotwica S; Niewodniczy A; Split W
    Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of vegetovascular dystonia with beta-blockaders and tranquilizers].
    Zubarev IuG; Kulakov SA
    Sov Med; 1985; (3):83-5. PubMed ID: 2862710
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and treatment of beta-adrenergic receptor hyperresponsiveness. A critical appraisal.
    Bourne HR; Thomson PD; Melmon KL
    Arch Intern Med; 1970 Jun; 125(6):1063-6. PubMed ID: 4378135
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperkinetic heart syndrome].
    Linss G
    Z Arztl Fortbild (Jena); 1985; 79(2):63-5. PubMed ID: 2859706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.